title: Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?
authors.affiliation: Department of Pediatrics, Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: John J
authors.initials: JJ
authors.lastname: Strouse
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000453:epidemiology; D002648:Child; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D006918:Hydroxyurea